• Pharma
  • May 7, 2025
  • 145 views
Neutral Alembic Pharma; target of Rs 930: Motilal Oswal

Motilal Oswal’s research report on Alembic Pharma Alembic Pharma (ALPM) delivered a better-than-expected performance in 4QFY25. A strong performance in export markets was offset partly by a muted show in…

Goa’s Game Changing Tuberculosis Diagnosis Technology attracts Massive Investment

Goa/ India: Goa-based Molbio Diagnostics, which provides innovative solutions for universal access to high-quality healthcare, announced that Temasek has invested $85 million in the company. Molbio is known for its…